178 related articles for article (PubMed ID: 18026859)
1. P53 gene mutations in pituitary carcinomas.
Tanizaki Y; Jin L; Scheithauer BW; Kovacs K; Roncaroli F; Lloyd RV
Endocr Pathol; 2007; 18(4):217-22. PubMed ID: 18026859
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
3. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
4. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
5. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
6. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Shimada S; Shiomori K; Tashima S; Tsuruta J; Ogawa M
Br J Cancer; 2001 Jun; 84(11):1497-504. PubMed ID: 11384100
[TBL] [Abstract][Full Text] [Related]
7. Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
Tziortzioti V; Ruebel KH; Kuroki T; Jin L; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(2):125-36. PubMed ID: 11579678
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations in gastric adenomas.
Tohdo H; Yokozaki H; Haruma K; Kajiyama G; Tahara E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(3):191-5. PubMed ID: 8097076
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan.
Reincke M; Wachenfeld C; Mora P; Thumser A; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3636-8. PubMed ID: 8855814
[TBL] [Abstract][Full Text] [Related]
10. H-ras mutations in human pituitary carcinoma metastases.
Pei L; Melmed S; Scheithauer B; Kovacs K; Prager D
J Clin Endocrinol Metab; 1994 Apr; 78(4):842-6. PubMed ID: 8157709
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV
Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.
Kubicka S; Trautwein C; Schrem H; Tillmann H; Manns M
J Hepatol; 1995 Oct; 23(4):412-9. PubMed ID: 8655958
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations and histological type of invasive breast carcinoma.
Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
[TBL] [Abstract][Full Text] [Related]
15. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
16. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
Challen C; Lunec J; Warren W; Collier J; Bassendine MF
Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in sporadic adrenocortical tumors.
Ohgaki H; Kleihues P; Heitz PU
Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
[TBL] [Abstract][Full Text] [Related]
20. p53 mutation in carcinomas arising in ovarian cystic teratomas.
Fujii T; Oguni S; Kikuchi M; Kanai N; Saito K
Pathol Int; 1995 Sep; 45(9):649-54. PubMed ID: 8548037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
